Use of a FLAER-based WBC assay in the primary screening of PNH clones

American Journal of Clinical Pathology

Volumn 132, Issue 4, 2009, Pages 564-572

  Sutherland, D Robert ^a,d   Kuek, Nancy ^a   Azcona Olivera, Juan ^b   Anderson, Tanya ^a   Acton, Erica ^a   Barth, David ^a   Keeney, Michael ^c  

^a UNIVERSITY HEALTH NETWORK   (Canada)

^b R and D Systems Inc   (United States)

^c LONDON HEALTH SCIENCES CENTRE   (Canada)

^d TORONTO GENERAL HOSPITAL   (Canada)

Author keywords

FLAER assay; Flow cytometry; Fluorescent aerolysin assay; Paroxysmal nocturnal hemoglobinuria clones

Indexed keywords

CD14 ANTIGEN; CD33 ANTIGEN; CD45 ANTIGEN; AEROLYSIN; BACTERIAL TOXIN; CD59 ANTIGEN; DIAGNOSTIC AGENT; FLUORESCEIN ISOTHIOCYANATE; PORE FORMING CYTOTOXIC PROTEIN;

ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOLECULAR CLONING; MONOCYTE; NEUTROPHIL; PAROXYSMAL NOCTURNAL HEMOGLOBINURIA; PRIORITY JOURNAL; SCREENING; APLASTIC ANEMIA; CELL CLONE; COMPARATIVE STUDY; ERYTHROCYTE COUNT; IMMUNOLOGY; LEUKOCYTE COUNT; METHODOLOGY; MYELODYSPLASTIC SYNDROME; SENSITIVITY AND SPECIFICITY;

ANEMIA, APLASTIC; ANTIGENS, CD59; BACTERIAL TOXINS; CLONE CELLS; ERYTHROCYTE COUNT; FLOW CYTOMETRY; FLUORESCEIN-5-ISOTHIOCYANATE; HEMOGLOBINURIA, PAROXYSMAL; HUMANS; LEUKOCYTE COUNT; MYELODYSPLASTIC SYNDROMES; PORE FORMING CYTOTOXIC PROTEINS; SENSITIVITY AND SPECIFICITY;

EID: 70349579693     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/AJCPMRDZZFQM7YJ4     Document Type: Article

References (24)

1. Dacie JV. Paroxysmal nocturnal haemoglobinuria. Proc R Soc Med. 1963;56:587-596.
2. Oni SB, Osunkoya BO, Luzzatto L. Paroxysmal nocturnal hemoglobinuria: evidence for monoclonal origin of abnormal red cells. Blood. 1970;36:145-152.
3. Miyata T, Takeda J, Iida Y, et al. The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993;259:1318-1320. (Pubitemid 23100269)
4. Takeda J, Miyata T, Kawagoe K, et al. Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. Cell. 1993;73:703-711. (Pubitemid 23159009)
5. Nafa K, Bessler M, Castro-Malaspina H, et al. The spectrum of somatic mutations in the PIG-A gene in paroxysmal nocturnal hemoglobinuria includes large deletions and small duplications. Blood Cells Mol Dis. 1998;24:370-384. (Pubitemid 28524836)
6. Rosse WF, Ware RE. The molecular basis of paroxysmal nocturnal hemoglobinuria. Blood. 1995;86:3277-13268
7. Dunn DE, Tanawattanacharoen P, Boccuni P, et al. Paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure syndromes. Ann Intern Med. 1999;131:401-408. (Pubitemid 29444429)
8. Hillmen P, Lewis SM, Bessler M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333:1253-1258.
9. Nicholson-Weller A, March JP, Rosenfeld JP, et al. Affected erythrocytes of patients with paroxysmal nocturnal hemoglobinuria are deficient in the complement regulatory protein, decay acceleration factor. Proc Natl Acad Sci U S A. 1983;80:5066-5070.
10. Holguin MH, Frederick LR, Bernshaw NJ, et al. Isolation and characterization of a membrane protein from normal human erythrocytes that inhibits reactive lysis of the erythrocytes of paroxysmal nocturnal hemoglobinuria. J Clin Invest. 1989;84:7-17.
11. Yamashina M, Ueda E, Kinoshita T, et al. Inherited complete deficiency of 20-kilodalton homologous restriction factor (CD59) as a cause of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1990;323:1184-1189. (Pubitemid 20347405)
12. van der Schoot CE, Huizinga TW, van't Veer-Korthof ET, et al. Deficiency of glycosyl-phosphatidylinositol-linked membrane glycoproteins of leukocytes in paroxysmal nocturnal hemoglobinuria, description of a new diagnostic cytofluorometric assay. Blood. 1990;76:1853-1859.
13. Hall SE, Rosse WF. The use of monoclonal antibodies and flow cytometry in the diagnosis of paroxysmal nocturnal hemoglobinuria. Blood. 1996;87:5332-5340. (Pubitemid 26189877)
14. Parker C, Omine M, Richards S, et al; for the International PNH Interest Group. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106:3699-3709.
15. Howard SP, Buckley JT. Activation of the hole-forming toxin aerolysin by extracellular processing. J Bacteriol. 1985;163:336-340.
16. Diep DB, Nelson KL, Raja SM, et al. Glycosylphosphatidylinositol anchors of membrane glycoproteins are binding determinants for the channel-forming toxin aerolysin. J Biol Chem. 1998;273:2355-2360.
17. Brodsky RA, Mukhina GL, Nelson KL, et al. Resistance of paroxysmal nocturnal hemoglobinuria cells to the glycosylphosphatidylinositol-binding toxin aerolysin. Blood. 1999;93:1749-1756. (Pubitemid 29102504)
18. Brodsky RA, Mukhina GL, Li S, et al. Improved detection and characterization of paroxysmal nocturnal hemoglobinuria using fluorescent aerolysin. Am J Clin Pathol. 2000;114:459-466. (Pubitemid 33049682)
19. Mukhina GL, Buckley JT, Barber JP, et al. Multilineage glycosylphosphatidylinositol anchor-deficient haematopoiesis in untreated aplastic anaemia. Br J Haematol. 2001;115:476-482.
20. Peghini PE, Fehr J. Clinical evaluation of an aerolysin-based screening test for paroxysmal nocturnal haemoglobinuria. Cytometry B Clin Cytom. 2005;67:13-18. (Pubitemid 41291789)
21. Sutherland DR, Kuek N, Davidson J, et al. Diagnosing PNH with FLAER and multiparameter flow cytometry. Cytometry B Clin Cytom. 2007;72:167-177. (Pubitemid 46676749)
22. Mortari F, Pulvermacher PM, Johnson AM, inventors; Research & Diagnostic Systems, assignee. Stabilizing solution for cells and tissues. US 2007 Patent No. 7,267,980. September 11, 2007.
23. Hall C, Richards S, Hillmen P. Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003;102:3587-3591. (Pubitemid 37409375)
24. Moyo VM, Mukhina GL, Garrett ES, et al. Natural history of paroxysmal nocturnal haemoglobinuria using modern diagnostic assays. Br J Haematol. 2004;126:133-138.